GCI Virtual Summit Thought Leader – Shane Duncan, Cann Group
Shane participated as a thought leader at the GCI Virtual Summit 2020, joining 1000+ registered global leaders in both cannabis and psychedelics.
Check out his bio below:
Shane Duncan joined Cann Group in December 2018 and is a broadly skilled consumer healthcare, medical device and pharmaceutical sales and marketing executive with a proven record of launching, establishing, and growing businesses/brands/commercial opportunities. Shane currently oversees the Commercial, Cultivation, Manufacturing and R&D programs for Cann Group. He has extensive global experience in strategy development, pre-commercialisation planning, medical education and product launch execution for several high value products.
Shane Duncan established and lead the Nth American Commercial Operations for Australian start-up company Rhinomed (ASX:RNO) for 3 years and has broad operational experience in a number of therapeutic areas including Respiratory, Sleep, Pain Management, Exercise Science and Fitness, Neuroscience, Cardiology, Endocrinology, and Vaccines.
If you are a leader operating in either the cannabis or psychedelics industries, check out the GCI Virtual Summit today! You can submit an application for a complimentary ticket for our 2021 Summit here.
You can also check out exclusive interviews with some of our GCI Virtual Summit thought leaders on the Content Hub.